Diepenbeek, Belgium, 14 October 2020 – Cannovex BV (the ‘Company’ or ‘Cannovex), a developer of cannabinoid-based medicines today announces that it has been awarded a EUR 0.5 million development grant…
Medicinal cannabis, cannabinoid-based medicine,… what’s in a name? This infographic provides an overview of the various concepts. Cannovex is focusing on concept 4.0 – i.e. the development of cannabinoid-based medicines.
Our Partners
Cannovex has entered into partnerships with universities and institutions for scientific research and business development, both in Belgium as in The Netherlands. Cannovex is open for partnerships to accomplish its mission to improve patients’ lives by developing cannabinoid-based medicines.